P3‐053: Existing data support wild‐type mouse is a suitable preclinical model for predicting human CSF abeta efficacy of gamma secreatase inhibitors
Liming Zhang(North China University of Technology), Jennifer L. Liras(Pfizer (United States)), Hugh A. Barton, Charles E. Nolan(Pfizer (United States)), Ashley Robshaw(Pfizer (United States)), Stacey L. Becker(Pfizer (United States)), David Riddell(Eli Lilly (United States)), Yasong Lu(Pfizer (United States)), Emily Miller(Pfizer (United States))
Cited by 0
Related Papers
ApoE Promotes the Proteolytic Degradation of Aβ
|Neuron|2008|869
Murine Mammary Carcinoma Exosomes Promote Tumor Growth by Suppression of NK Cell Function
|The Journal of Immunology|2006|487
Application of the Bicyclo[1.1.1]pentane Motif as a Nonclassical Phenyl Ring Bioisostere in the Design of a Potent and Orally Active γ-Secretase Inhibitor
|Journal of Medicinal Chemistry|2012|460
Impact of Apolipoprotein E (ApoE) Polymorphism on Brain ApoE Levels
|Journal of Neuroscience|2008|351
Compartmentalization of β-secretase (Asp2) into low-buoyant density, noncaveolar lipid rafts
|Current Biology|2001|302